Northwestern researchers identify a reduced CSF protein signal in schizophrenia and show a synthetic version restores brain circuit activity in mice.
Patrick Campbell
Advertisement
Mr Campbell is the vice president of content at MJH Life Sciences.
Articles by Patrick Campbell
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults
2
Quiet Comfort: New Details on COMP360 Psilocybin Administration Sessions for the Treatment of PTSD
3
Preventing Alzheimer Disease After Brain Injury: Targeting TNF With XPro1595
4
Phase 2 Topline Results From ZEPHYR Trial: ML-007C-MA for the Treatment of Schizophrenia
5